Data as of Jul 25
| +0.06 / +0.49%|
The 3 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 27.00, with a high estimate of 28.00 and a low estimate of 27.00. The median estimate represents a +119.16% increase from the last price of 12.32.
The current consensus among 4 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.